CD4 and myasthenia gravis: The pathogenesis of MG is relevant to CD4 + T cells, thus in the current study, we expected to investigate whether AS-IV ameliorates experimental autoimmune myasthenia gravis (EAMG) symptoms and affects EAMG by modulating the subsets of CD4 + T cells.